000 01526 a2200481 4500
005 20250512010257.0
264 0 _c19891228
008 198912s 0 0 jpn d
022 _a0030-6622
024 7 _a10.3950/jibiinkoka.92.1265
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSaito, T
245 0 0 _a[Clinical evaluation of local administration of RIL-2 in head and neck cancer].
_h[electronic resource]
260 _bNihon Jibiinkoka Gakkai kaiho
_cAug 1989
300 _a1265-70 p.
_bdigital
500 _aPublication Type: English Abstract; Journal Article
650 0 4 _aAdult
650 0 4 _aAged
650 0 4 _aAged, 80 and over
650 0 4 _aAntineoplastic Agents
_xtherapeutic use
650 0 4 _aCombined Modality Therapy
650 0 4 _aDrug Evaluation
650 0 4 _aFemale
650 0 4 _aHead and Neck Neoplasms
_xdrug therapy
650 0 4 _aHumans
650 0 4 _aInjections, Intralesional
650 0 4 _aInterleukin-2
_xadministration & dosage
650 0 4 _aMale
650 0 4 _aMiddle Aged
650 0 4 _aRecombinant Proteins
_xadministration & dosage
650 0 4 _aRemission Induction
700 1 _aKakiuti, H
700 1 _aKuki, K
700 1 _aYokota, M
700 1 _aJinnin, T
700 1 _aKimura, T
700 1 _aFujiwara, K
700 1 _aYoda, J
700 1 _aKunimoto, M
700 1 _aArai, H
773 0 _tNihon Jibiinkoka Gakkai kaiho
_gvol. 92
_gno. 8
_gp. 1265-70
856 4 0 _uhttps://doi.org/10.3950/jibiinkoka.92.1265
_zAvailable from publisher's website
999 _c2591099
_d2591099